burzynski research institute
(BZYR:OTC US)

Executive Profile*

Background*

Dr. Stanislaw R. Burzynski, MD, Ph.D., has been the Chairman and President of Burzynski Research Institute Inc. since its inception in 1984 and serves as its Chief Executive Officer and Principal Financial Officer. Dr. Burzynski serves as the Chief Executive Officer of Burzynski Clinic for Burzynski Research Institute Inc. He served as the Chief Financial Officer of Burzynski Research Institute Inc. He also served as Secretary and Treasurer of Burzynski Research Institute ... Inc. until March 1, 2012. He is the Founder and is a physician in private practice in Houston, Texas specializing in the treatment of cancer. He is listed in Who's Who In The World and a member in good standing with both the American and World Medical Associations. He is an internationally recognized physician and scientist who has pioneered the development and use of biologically active peptides in diagnosing, preventing, and treating cancer since 1967. From 1970 to 1977, he was a Researcher and Assistant Professor at Baylor College of Medicine in Houston. At Baylor, Dr. Burzynski's research was sponsored and partially funded by the National Cancer Institute. Also at Baylor, he authored and co-authored sixteen publications, including five concerning his research on peptides and their effect on human cancer, four of these publications were also co-authored by other doctors associated with M.D. Anderson Hospital and Tumor Institute and Baylor College of Medicine. In May 1977, Dr. Burzynski received a Certificate of Appreciation from Baylor College of Medicine and in that same year founded Burzynski Research Institute. He is a member of the American Medical Association, American Association for Cancer Research, Harris County Medical Society, New York Academy of Sciences, Society for Neuroscience, Texas Medical Association, the Society of Sigma Xi, the Society of Neuro-oncology and has privileges at Twelve Oaks Medical Center at River Oaks located near Burzynski Research Institute in Houston. He is the author of 172 scientific publications, presenter of scientific papers at major international conventions, and has been awarded 166 patents covering 39 countries for his Antineoplaston treatment. Other groups are working in conjunction with him, including researchers at the University Kurume Medical School in Japan. In 1967, Dr. Burzynski graduated from the Medical Academy in Lublin, Poland with an M.D. degree with distinction, finishing first in his class of 250, and subsequently earned his Ph.D. in Biochemistry.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
BZYR:US	$0.08 USD	0.00

COMPETITOR COMPENSATION